| Bid | 55.71 |
| Market Cap | 9.29B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 2.07 |
| PE Ratio (ttm) | 29.59 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 62.86 |
| Volume | 1,089,191 |
| Avg. Volume (20D) | 1,464,945 |
| Open | 63.84 |
| Previous Close | 62.95 |
| Day's Range | 60.56 - 63.95 |
| 52-Week Range | 48.07 - 94.86 |
| Beta | undefined |
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen ide...
Analyst Forecast
According to 11 analyst ratings, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $72, which is an increase of 17.54% from the latest price.
Next Earnings Release
Analysts project revenue of $964.32M, reflecting a 12.85% YoY growth and earnings per share of 0.74, making a 5.71% increase YoY.
3 weeks ago · businesswire.com
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR FacilityZÜRICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker announces the acceptance of a 1.2 GHz Ascend™ Nuclear Magnetic Resonance (NMR) spectrometer at the Swiss High-field NMR Facility, operated jointly by th...
